VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,003,205 | -22.5% | 37,280 | -13.3% | 0.50% | -21.3% |
| Q2 2023 | $1,294,730 | +10.8% | 43,000 | +19.0% | 0.64% | +2.6% |
| Q1 2023 | $1,169,032 | +203.7% | 36,137 | +169.1% | 0.62% | +193.4% |
| Q4 2022 | $384,932 | +19.2% | 13,431 | +0.0% | 0.21% | +5.0% |
| Q3 2022 | $323,000 | -15.2% | 13,428 | -3.5% | 0.20% | -16.2% |
| Q2 2022 | $381,000 | -28.5% | 13,919 | 0.0% | 0.24% | -14.6% |
| Q1 2022 | $533,000 | +28.7% | 13,919 | +7.5% | 0.28% | +40.5% |
| Q4 2021 | $414,000 | +9.5% | 12,945 | +0.9% | 0.20% | +1.0% |
| Q3 2021 | $378,000 | -33.1% | 12,832 | -22.9% | 0.20% | -29.0% |
| Q2 2021 | $565,000 | -99.9% | 16,652 | -6.1% | 0.28% | +6.9% |
| Q1 2021 | $576,627,000 | +117579.0% | 17,742 | +30.2% | 0.26% | -2.6% |
| Q4 2020 | $490,000 | -9.8% | 13,624 | -1.8% | 0.27% | -18.3% |
| Q3 2020 | $543,000 | +98.9% | 13,874 | +86.0% | 0.33% | +89.6% |
| Q2 2020 | $273,000 | – | 7,460 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |